Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 100 for your search:
Drug:  prednisolone
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL03, NCT00199004

2.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 16 and under
Sponsor: Other
Protocol IDs: LAL-AR-N-2005, NCT00526409

3.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL04, NCT00199017

4.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: NILG-ALL 10/07, NCT00795756

5.

Phase: Phase III, Phase I
Type: Treatment
Status: Closed
Age: under 50
Sponsor:
Protocol IDs: DFCI-76006, DFCI-VAPA-10

6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 69
Sponsor:
Protocol IDs: CRC-TU-HO3001, EU-93029

7.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 65 and over
Sponsor:
Protocol IDs: CRC-TU-NH3003, EU-93028, NCT00002576

8.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 60
Sponsor: Other
Protocol IDs: EORTC-06951, FRE-LALA-94, NCT00002700

9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 15 at initial diagnosis
Sponsor:
Protocol IDs: MRC-LEUK-UKALL-R2, EU-95039

10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 1 and under 15
Sponsor:
Protocol IDs: MRC-LEUK-UKALL-XI, EU-95036

11.

Phase: Phase III
Type: Treatment
Status: Completed
Age: over 6 months to under 21
Sponsor: NCI, Other
Protocol IDs: 5961, COG-C5961, CCG-5961, SFOP-LMB-96, CCLG-NHL-9600, EU-96048, CDR0000064702, NCT00002757

12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 75
Sponsor:
Protocol IDs: MRC-UKLG-LY07, EU-97004, NCT00002987

13.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 1 to 17
Sponsor: NCI, Other
Protocol IDs: CDR0000066202, DFCI-95001, DFCI-FDR001197, NCI-G99-1651, NCT00004034

14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor:
Protocol IDs: MRC-UKLG-LY09, EU-98020, NCT00003421

15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 15
Sponsor:
Protocol IDs: UKCCSG-NHL-9503, EU-98012, NCT00003423

16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 18
Sponsor: Other
Protocol IDs: MRC-LEUK-ALL97, EU-97032, NCT00003437

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: RHG-MM97, EU-98030, NCT00003603

18.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 18
Sponsor: Other
Protocol IDs: CDR0000066840, EORTC-58951, NCT00003728

19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 65
Sponsor: Other
Protocol IDs: SNLG-NHL-Va, EU-98032, NCT00003815

20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: Other
Protocol IDs: LRF-CLL4, LRG-MRC-LEUK-CLL4, EU-99030, MRC-LEUK-CLL4, NCT00004218, EUDRACT-58585610, ISRCTN58585610

21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: under 15
Sponsor: NCI
Protocol IDs: POG-7220/21

22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 59
Sponsor: Other
Protocol IDs: BNLI-CHOPVPMITCEBO-GOODRISK, EU-99052, NCT00005867

23.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 365 days and under
Sponsor: Other
Protocol IDs: CDR0000068529, ICU-INTERFANT99, UKCCSG-LK-1999-05, EU-20063, EU-20588, NCT00015873

24.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21
Sponsor:
Protocol IDs: MDA-P-7730n

25.

Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: EORTC-10792
1     
New Search